Anecream 5 Cream
NDC Package 24357-702-15
Package Information
Anecream 5 (lidocaine 5%) cream is a medication used to help reduce itching and pain from certain skin conditions (such as scrapes, minor skin irritations, insect bites). This formulation utilizes a cream delivery system. Marketed by Focus Health Group, this product is identified by NDC 24357-702 and is authorized under FDA application M007.
Identification & Billing
- RxCUI: 1366789 - lidocaine 5 % Rectal Cream
- RxCUI: 1366789 - lidocaine 50 MG/ML Rectal Cream
- RxCUI: 1422078 - AneCream5 5 % Rectal Cream
- RxCUI: 1422078 - lidocaine 50 MG/ML Rectal Cream [AneCream]
- RxCUI: 1422078 - AneCream (lidocaine 5 % ) Rectal Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 24357 - Focus Health Group
- 24357-702 - Anecream 5
- 24357-702-15 - 1 TUBE in 1 CARTON / 15 g in 1 TUBE
- 24357-702 - Anecream 5
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (24357-702). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 24357-702-15 identifies a specific commercial package of 1 tube in 1 carton / 15 g in 1 tube of Anecream 5, a human over the counter drug labeled by Focus Health Group. This product is billed per "GM" gram and contains an estimated amount of 15 billable units per package. This cream is formulated for topical use and contains lidocaine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Focus Health Group on December 20, 2011. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This product is used to help reduce itching and pain from certain skin conditions (such as scrapes, minor skin irritations, insect bites). It may also be used to help relieve nerve pain after shingles (infection with herpes zoster virus). Lidocaine belongs to a class of drugs known as local anesthetics. It works by causing a temporary loss of feeling in the area where you apply the patch.
How is this Focus Health Group product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 24357070215. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 15 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.